Immunex fears guilt by association

Immunex Corp. moved quickly last week to counter bad news on the use of certain colony stimulating factors in older patients with acute non-lymphocytic leukemia (acute myelogenous leukemia), with a statement emphasizing positive results of its Leukine GM-CSF, which is awaiting FDA approval to speed neutrophil recovery in AML patients after chemotherapy.


Read the full 532 word article

How to gain access

Continue reading with a
two-week free trial.